Late Kidney Effects of Childhood Cancer and Cancer Therapies

Farber, 1948, Temporary remissions in acute leukemia in children produced by folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin), New Engl J Med, 238, 787, 10.1056/NEJM194806032382301 Oeffinger, 2006, Chronic health conditions in adult survivors of childhood cancer, New Engl J Med, 355, 1572, 10.1056/NEJMsa060185 Gibson, 2018, Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort, Lancet Oncol, 19, 1590, 10.1016/S1470-2045(18)30537-0 Abbas, 2015, Renal toxicities of targeted therapies, Target Oncol, 10, 487, 10.1007/s11523-015-0368-7 Sury, 2019, The nephrotoxicity of new immunotherapies, Expert Rev Clin Phar, 12, 513, 10.1080/17512433.2019.1613888 Raina, 2017, Hematopoietic stem cell transplantation and acute kidney injury in children: a comprehensive review, Pediatr Transpl, 21, 1, 10.1111/petr.12935 Ruggiero, 2017, Renal toxicity and chemotherapy in children with cancer, Br J Clin Pharmaco, 83, 2605, 10.1111/bcp.13388 Kröning, 2000, Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines, Cancer Chemoth Pharm, 45, 43, 10.1007/PL00006741 Barton, 2018, Identifying cisplatin-induced kidney damage in paediatric oncology patients, Pediatr Nephrol, 33, 1467, 10.1007/s00467-017-3765-6 Brock, 1991, Partial reversibility of cisplatin nephrotoxicity in children, J Pediatr, 118, 531, 10.1016/S0022-3476(05)83372-4 Ariceta, 1997, Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis, Med Pediatr Oncol, 28, 35, 10.1002/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U Kooijmans, 2019, Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer, Cochrane Db Syst Rev, 3, CD008944 Skinner, 2009, Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors, Eur J Cancer, 45, 3213, 10.1016/j.ejca.2009.06.032 Stöhr, 2007, Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system, Pediatr Blood Cancer, 48, 140, 10.1002/pbc.20812 Musiol, 2016, Renal function in children treated for central nervous system malignancies, Child’s Nerv Syst, 32, 1431, 10.1007/s00381-016-3130-2 McMahon, 2018, Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study, Pediatr Nephrol, 33, 2311, 10.1007/s00467-018-3976-5 Goren, 1987, Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy, Cancer Res, 47, 1457 Rossi, 1994, Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients, J Clin Oncol, 12, 159, 10.1200/JCO.1994.12.1.159 Hanly, 2009, Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention, Expert Opin Drug Saf, 8, 155, 10.1517/14740330902808169 Stöhr, 2007, Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System, Pediatr Blood Cancer, 48, 447, 10.1002/pbc.20858 Rossi, 1999, Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients, Med Pediatr Oncol, 32, 177, 10.1002/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H Oberlin, 2009, Long-term evaluation of ifosfamide-related nephrotoxicity in children, J Clin Oncol, 27, 5350, 10.1200/JCO.2008.17.5257 Goldstein, 2013, Nephrology for the AKIAG of the as of. AKI Transition of care: a potential Opportunity to detect and prevent CKD, Clin J Am Soc Nephro, 8, 476, 10.2215/CJN.12101112 Chanchlani, 2019, Secular trends in incidence, modality and mortality with dialysis receiving AKI in children in Ontario: a population-based cohort study, Clin J Am Soc Nephro, 14, 1288, 10.2215/CJN.08250718 Mulder, 2013, Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study, Cancer Epidemiol Prev Biomarkers, 22, 1736, 10.1158/1055-9965.EPI-13-0036 Knijnenburg, 2012, Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors, Clin J Am Soc Nephro, 7, 1416, 10.2215/CJN.09620911 Cochat, 2019, Towards adulthood with a solitary kidney, Pediatr Nephrol, 34, 2311, 10.1007/s00467-018-4085-1 Cohen, 2003, Radiation nephropathy, Semin Nephrol, 23, 486, 10.1016/S0270-9295(03)00093-7 Neu, 2017, Prospective analysis of long-term renal function in survivors of childhood Wilms tumor, Pediatr Nephrol, 32, 1915, 10.1007/s00467-017-3673-9 Green, 2020, Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study, Pediatr Blood Cancer, 67, 1, 10.1002/pbc.28271 Chu, 2021, Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study, J Pediatr, 230, 215, 10.1016/j.jpeds.2020.12.005 Jones, 2008, Renal late effects in patients treated for cancer in childhood: a report from the Children’s Oncology Group, Pediatr Blood Cancer, 51, 724, 10.1002/pbc.21695 Dekkers, 2013, Long-term nephrotoxicity in adult survivors of childhood cancer, Clin J Am Soc Nephro, 8, 922, 10.2215/CJN.09980912 Astor, 2008, Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population, Am J Epidemiol, 167, 1226, 10.1093/aje/kwn033 Brenner, 1996, The hyperfiltration theory: a paradigm shift in nephrology, Kidney Int, 49, 1774, 10.1038/ki.1996.265 Ramirez, 2016, Yield of urinalysis screening in pediatric cancer survivors, Pediatr Blood Cancer, 63, 893, 10.1002/pbc.25897 Green, 2021, Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime cohort study, J Am Soc Nephrol, 32, 983, 10.1681/ASN.2020060849 Dengel, 2014, Signs of early sub-clinical atherosclerosis in childhood cancer survivors, Pediatr Blood Cancer, 61, 532, 10.1002/pbc.24829 Krystal, 2015, Arterial stiffness in childhood cancer survivors, Pediatr Blood Cancer, 62, 1832, 10.1002/pbc.25547 Armstrong, 2013, Modifiable risk factors and major cardiac events among adult survivors of childhood cancer, J Clin Oncol, 31, 3673, 10.1200/JCO.2013.49.3205 Mulrooney, 2020, Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort, Bmj, 368, 1 Interiano, 2017, Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor, J Pediatr Surg, 52, 98, 10.1016/j.jpedsurg.2016.10.027 Cardous-Ubbink, 2010, Hypertension in long-term survivors of childhood cancer: a nested case-control study, Eur J Cancer, 46, 782, 10.1016/j.ejca.2010.01.002 Hoffmeister, 2010, Hypertension in long-term survivors of pediatric hematopoietic cell transplantation, Biol Blood Marrow Tr, 16, 515, 10.1016/j.bbmt.2009.11.018 Geenen, 2010, Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy, Pediatr Blood Cancer, 55, 690, 10.1002/pbc.22518 Fuchs, 2020, High blood pressure and cardiovascular disease, Hypertension, 75, 285, 10.1161/HYPERTENSIONAHA.119.14240 Skinner Kremer, 2013, A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the international late effects of Childhood Cancer Guideline Harmonization Group, Pediatr Blood Cancer, 60, 543, 10.1002/pbc.24445